Absurd bashing. The Bril-OM Phase 2 was spectacular. The FDA is "collaborative." There is NO treatment for oral mucositis. Even if Bril-OM only helped 1/3 of the patients (which is less than half of the number helped in Phase 2), they would still approve it. FDA has approved drugs that help fewer than 1/3 of the people. And there is NO reason to think that Bril-OM wouldn't have great results in Phase 3, especially since the good results so far will give patients a powerful incentive to comply with the protocol and make sure they get every single dose in, on schedule.
But, at least we know now that the scottsmith gang is back to bashing. Thanks for the data point, sqott.
(3)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links